An Engineered Bivalent Neuregulin Protects Against Doxorubicin-Induced Cardiotoxicity With Reduced Proneoplastic Potential

Circulation - United States
doi 10.1161/circulationaha.113.002203
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Diazoxide Protects Against Doxorubicin-Induced Cardiotoxicity in the Rat

BMC pharmacology & toxicology
MedicinePharmacology
2014English

Resveratrol Protects Against Doxorubicin-Induced Cardiotoxicity in Aged Hearts Through the SIRT1-USP7 Axis

Journal of Physiology
PhysiologySports Science
2015English

Cardioprotective Potential of Murraya Koenigii (L.) Spreng. Leaf Extract Against Doxorubicin-Induced Cardiotoxicity in Rats

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2020English

Thrombopoietin Protects H9C2 Cells From Excessive Autophagy and Apoptosis in Doxorubicin‑induced Cardiotoxicity

Oncology Letters
Cancer ResearchOncology
2017English

The Protective Effect of Metformin Against Doxorubicin Induced Cardiotoxicity in Rabbits

Al Mustansiriyah Journal of Pharmaceutical Sciences
2019English

Anticancer Prodrugs of Butyric Acid and Formaldehyde Protect Against Doxorubicin-Induced Cardiotoxicity

British Journal of Cancer
Cancer ResearchOncology
2007English

Neuregulin1-ErbB Signaling in Doxorubicin-Induced Cardiotoxicity

2012English

Amelioration of Doxorubicin‑induced Cardiotoxicity by Resveratrol

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2014English

The Protective Effects of Silymarin Against Doxorubicin-Induced Cardiotoxicity and Hepatotoxicity in Rats

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy